Literature DB >> 3619093

Neurolytic celiac plexus block for pancreatic cancer pain.

D L Brown, C K Bulley, E L Quiel.   

Abstract

Neurolytic celiac plexus block (NCPB) is an effective method for relief of the pain of pancreatic cancer, but many physicians are reluctant to use the technique because of the perception that the incidence of complications is high. We analyzed the incidence of complications and the quality of pain relief obtained during the use of NCPB in 136 patients with pancreatic cancer. Eighty-five percent of the patients had good pain relief that, in 75% of cases, lasted through the patients' remaining life. No permanent neurologic complications resulted, although two patients had a pneumothorax. Radiographically guided needle placement did not affect quality of pain relief or the incidence of complications. This neurolytic pain block is effective, has a low incidence of neurologic complications, and deserves more widespread use in patients with pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619093

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

Review 1.  Celiac block for the treatment of pancreatic pain.

Authors:  S Ischia; E Polati; G Finco; L Gottin
Journal:  Curr Rev Pain       Date:  2000

2.  Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer pain.

Authors:  Takeshi Kitoh; Satoshi Tanaka; Koichi Ono; Yukihiro Ohfusa; Hiroaki Ina; Tetsutaro Otagiri
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

3.  Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain.

Authors:  Chun-Lei Zhang; Ting-Jie Zhang; Yu-Na Guo; Li-Qiang Yang; Ming-Wei He; Jing-Zhe Shi; Jia-Xiang Ni
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 4.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

5.  Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial.

Authors:  K D Lillemoe; J L Cameron; H S Kaufman; C J Yeo; H A Pitt; P K Sauter
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis.

Authors:  Fan Lu; Jifu Dong; Yuming Tang; He Huang; Hui Liu; Li Song; Kexian Zhang
Journal:  Support Care Cancer       Date:  2017-09-27       Impact factor: 3.603

Review 7.  Coeliac plexus block for chronic pain syndromes.

Authors:  F Fugère; G Lewis
Journal:  Can J Anaesth       Date:  1993-10       Impact factor: 5.063

Review 8.  Techniques and results of neurolysis for chronic pancreatitis and pancreatic cancer pain.

Authors:  Marc Noble; Frank G Gress
Journal:  Curr Gastroenterol Rep       Date:  2006-04

Review 9.  The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.

Authors:  Mansoor M Aman; Ammar Mahmoud; Timothy Deer; Dawood Sayed; Jonathan M Hagedorn; Shane E Brogan; Vinita Singh; Amitabh Gulati; Natalie Strand; Jacqueline Weisbein; Johnathan H Goree; Fangfang Xing; Ali Valimahomed; Daniel J Pak; Antonios El Helou; Priyanka Ghosh; Krishna Shah; Vishal Patel; Alexander Escobar; Keith Schmidt; Jay Shah; Vishal Varshney; William Rosenberg; Sanjeet Narang
Journal:  J Pain Res       Date:  2021-07-16       Impact factor: 3.133

10.  Modulation of visceral nociception, inflammation and gastric mucosal injury by cinnarizine.

Authors:  Omar M E Abdel-Salam
Journal:  Drug Target Insights       Date:  2007-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.